Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7314923 Nucleoside and oligonucleotide analogues

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
May 5, 2003
Date of Patent
January 1, 2008
Patent Application Number
10430705
Patent Citations Received
‌
US Patent 12091662 Compositions for modulating tau expression
0
‌
US Patent 11963974 Antisense oligonucleotide and composition for prevention or treatment of glycogen storage disease type Ia
0
‌
US Patent 12060558 Methods and compositions for treatment of cholesteryl ester storage disease
0
‌
US Patent 11697814 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
0
‌
US Patent 11781135 Methods for treating Alzheimer's disease
‌
US Patent 11827910 Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
0
‌
US Patent 11873490 Antisense oligomers for treatment of conditions and diseases
0
‌
US Patent 11891605 Reducing intron retention
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7314923
Patent Primary Examiner
‌
Patrick Lewis

Find more entities like US Patent 7314923 Nucleoside and oligonucleotide analogues

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.